Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1 Comparison of perioperative patient characteristics by groups

Published byDuane Booker Modified over 5 years ago

Similar presentations

Presentation on theme: "Table 1 Comparison of perioperative patient characteristics by groups"— Presentation transcript:

1 Table 1 Comparison of perioperative patient characteristics by groups
Left ventricular architecture after valve replacement due to critical aortic stenosis: an approach to dis-/qualify the myth of valve prosthesis–patient mismatch?☆ Eur J Cardiothorac Surg. 2001;19(6): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

2 Table 2 Comparison of primary (I) and secondary (II) endpoint variables by groups<sup>a</sup> Left ventricular architecture after valve replacement due to critical aortic stenosis: an approach to dis-/qualify the myth of valve prosthesis–patient mismatch?☆ Eur J Cardiothorac Surg. 2001;19(6): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

3 Fig. 1 LVMM<sub>index</sub>, left ventricular myocardial mass index; P<sub>T</sub>, P value for the factor time; P<sub>T+G</sub>, P value for interaction of the factors time and group. Left ventricular architecture after valve replacement due to critical aortic stenosis: an approach to dis-/qualify the myth of valve prosthesis–patient mismatch?☆ Eur J Cardiothorac Surg. 2001;19(6): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

4 Fig. 2 WT<sub>sys1</sub>, systolic wall thickness at position 1 (anterior, superior); WT<sub>sys2</sub>, systolic wall thickness at position 2 (anterior, median); WT<sub>sys3</sub>, systolic wall thickness at position 3 (anterior, inferior); WT<sub>sys4</sub>, systolic wall thickness at position 4 (apical); WT<sub>sys5</sub>, systolic wall thickness at position 5 (posterior, inferior); WT<sub>sys6</sub>, systolic wall thickness at position 6 (posterior); WT<sub>sys7</sub>, systolic wall thickness at position 7 (posterior and posterolateral). (Solid line), control T<sub>0</sub>; (semi-interrupted line), control T<sub>1</sub>; (interrupted line), control T<sub>2</sub>. Left ventricular architecture after valve replacement due to critical aortic stenosis: an approach to dis-/qualify the myth of valve prosthesis–patient mismatch?☆ Eur J Cardiothorac Surg. 2001;19(6): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

5 Fig. 3 WT<sub>dias1</sub>, diastolic wall thickness at position 1 (anterior, superior); WT<sub>dias2</sub>, diastolic wall thickness at position 2 (anterior, median); WT<sub>dias3</sub>, diastolic wall thickness at position 3 (anterior, inferior); WT<sub>dias4</sub>, diastolic wall thickness at position 4 (apical); WT<sub>dias5</sub>, diastolic wall thickness at position 5 (posterior, inferior and diaphragmal); WT<sub>dias6</sub>, diastolic wall thickness at position 6 (posterior); WT<sub>dias7</sub>, diastolic wall thickness at position 7 (posterior and posterolateral). (Solid line), control T<sub>0</sub>; (semi-interrupted line), control T<sub>1</sub>; (interrupted line), control T<sub>2</sub>. Left ventricular architecture after valve replacement due to critical aortic stenosis: an approach to dis-/qualify the myth of valve prosthesis–patient mismatch?☆ Eur J Cardiothorac Surg. 2001;19(6): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

6 Table 3 Logistic regression report
Left ventricular architecture after valve replacement due to critical aortic stenosis: an approach to dis-/qualify the myth of valve prosthesis–patient mismatch?☆ Eur J Cardiothorac Surg. 2001;19(6): doi: /S (01) Eur J Cardiothorac Surg | © 2001 Elsevier Science B.V. All rights reserved.Elsevier Science B.V.

Download ppt "Table 1 Comparison of perioperative patient characteristics by groups"

Similar presentations

Atrial and Ventricular Hypertrophy. ECG Features and Common Causes.

Atrial and Ventricular Hypertrophy. ECG Features and Common Causes.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5:580-588 A comparison of patient characteristics and 30-day mortality outcomes after.

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
Fig.1 Complexity of the surgeries according to BAS. Histogram.

Fig.1 Complexity of the surgeries according to BAS. Histogram.
Figure 1 Percentage of patients with and without multivessel coronary artery disease having normal result, ischaemia (Isch) in one or more than one territory.

Figure 1 Percentage of patients with and without multivessel coronary artery disease having normal result, ischaemia (Isch) in one or more than one territory.
Two-dimensional echocardiogram from a patient with severe hypertrophic cardiomyopathy. There is a severe increase in left ventricular wall thickness, with.

Two-dimensional echocardiogram from a patient with severe hypertrophic cardiomyopathy. There is a severe increase in left ventricular wall thickness, with.
Gary A. Bergeron, M.D., F.C.C.P., Nelson B. Schiller, M.D.  CHEST 

Gary A. Bergeron, M.D., F.C.C.P., Nelson B. Schiller, M.D.  CHEST 
Fig. 1. Concentric left ventricular hypertrophy by echocardiography

Fig. 1. Concentric left ventricular hypertrophy by echocardiography
Use of a Miniaturized Transesophageal Echocardiographic Probe in the Intensive Care Unit for Diagnosis and Treatment of a Hemodynamically Unstable Patient.

Use of a Miniaturized Transesophageal Echocardiographic Probe in the Intensive Care Unit for Diagnosis and Treatment of a Hemodynamically Unstable Patient.
Postoperative Left Ventricular Mass Regression After Aortic Valve Replacement for Aortic Stenosis  Hiroshi Tomoeda, MD, Tomohiro Ueda, MD, Hideki Teshima,

Postoperative Left Ventricular Mass Regression After Aortic Valve Replacement for Aortic Stenosis  Hiroshi Tomoeda, MD, Tomohiro Ueda, MD, Hideki Teshima,
Tissue Velocities and Myocardial Deformation in Asymptomatic and Symptomatic Aortic Stenosis  Helle Gervig Carstensen, MD, PhD, Linnea Hornbech Larsen,

Tissue Velocities and Myocardial Deformation in Asymptomatic and Symptomatic Aortic Stenosis  Helle Gervig Carstensen, MD, PhD, Linnea Hornbech Larsen,
Tomislav Mihaljevic, MD, Edward R

Tomislav Mihaljevic, MD, Edward R
Table 1 Cause of death for arrested organ donors

Table 1 Cause of death for arrested organ donors
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Table 1 Patient characteristics

Table 1 Patient characteristics
Fig. 1 Diagram of method C for bronchial closure

Fig. 1 Diagram of method C for bronchial closure
Table 1 Staging of resected tumours of the oesophagus

Table 1 Staging of resected tumours of the oesophagus
Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.

Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.
Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Similar presentations

Ads by Google